What's in Jiangsu Kanion Pharmaceutical Co., Ltd's pipeline?

Jiangsu Kanion Pharmaceutical Co., Ltd has 6 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Jiangsu Kanion Pharmaceutical Co., Ltd's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiangsu-kanion-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jiangsu Kanion Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jiangsu Kanion Pharmaceutical Co., Ltd pipeline: 3 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Area
Sanjie analgesic capsule	Sanjie analgesic capsule	marketed
Ginkgolides Meglumine Injection	Ginkgolides Meglumine Injection	marketed
Tianshu capsule	Tianshu capsule	marketed	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Jiangsu Kanion Pharmaceutical Co., Ltd:

Cite this brief

Drug Landscape (2026). Jiangsu Kanion Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiangsu-kanion-pharmaceutical-co-ltd. Accessed 2026-05-17.